{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:08:05Z","timestamp":1789564085789,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate the clinical effect of intravitreal ranibizumab (IVR) and laser photocoagulation on diabetic macular edema (DME).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic search was conducted of five English databases from the establishment of each database to 31 January 2024, and a meta-analysis was performed using Review Manager 5.3 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      A total of 1,040 patients were included across 10 articles, where 531 patients had been treated with IVR and 509 with laser photocoagulation. The results of the meta-analysis showed that visual acuity improvement in the IVR group was better than in the laser photocoagulation group. The difference was statistically significant (best corrected visual acuity [BCVA], Mean Difference (MD) = 5.69, 95% confidence interval [CI]: 4.51, 6.86,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). There was no significant difference in BCVA based on Logarithm of the Minimum Angle of Resolution (logMAR) value (MD = \u22120.07, 95%CI: \u22120.15, \u22120.01,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.07). The improvement of macular edema in IVR was better than in the laser photocoagulation group (central macular thickness, MD = \u221230.93, 95% CI: \u221235.18, \u221226.68,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). There were more adverse reaction events in the IVR group than in the laser photocoagulation group, and the difference was statistically significant (odds ratio = 8.82, 95% CI: 3.06, 25.43,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intravitreal ranibizumab remains superior to laser photocoagulation in improving vision and reducing macular edema in DME, albeit with higher adverse events. These findings support IVR\u2019s continued relevance in contemporary practice, particularly where newer anti-vascular endothelial growth factor agents are unavailable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1608456","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:37:50Z","timestamp":1789562270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effect of intravitreal ranibizumab and laser photocoagulation on diabetic macular edema: a meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Linyu","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Hebei Provincial People\u2019s Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","article-title":"Investigation on the prevalence of diabetic macular edema and related factors","volume":"32","author":"Xiaolu","year":"2012","journal-title":"J Shanghai Jiao Tong University: Med Ed"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2165\/11538130-000000000-00000","article-title":"Current approaches to the management od diabeitc retinopathy anddiabetic macular edema","volume":"70","author":"Boscia","year":"2010","journal-title":"Drugs"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1159\/000081203","volume":"36","author":"Bringmann","year":"2004","journal-title":"Ophthalmic Research"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(84)34102-1","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema","volume":"91","author":"Klein","year":"1984","journal-title":"Ophthalmology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-3225","article-title":"Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials","volume":"50","author":"Su\u00f1er","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ajo.2008.07.013","article-title":"Diabetic macular edema: what is focal and what is diffuse","volume":"146","author":"Browning","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(87)33527-4","article-title":"Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group","volume":"94","year":"1987","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13989","article-title":"Cochrane systematic review and Meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life","volume":"59","author":"Michaelis","year":"2018","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/1120672117750056","article-title":"Comparison of ranibizumab and subthreshold micropulse laser in treatment of macular edema secondary to branch retinal vein occlusion","volume":"28","author":"Buyru \u00d6zkurt","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2478\/folmed-2018-0081","article-title":"Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion","volume":"61","author":"Kumar","year":"2019","journal-title":"Folia Med (Plovdiv)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3000605231194462","DOI":"10.1177\/03000605231194462","article-title":"Efficacy of subthreshold micropulse laser photocoagulation therapy versus anti-vascular endothelial growth factor therapy for refractory macular edema secondary to non-ischemic branch retinal vein occlusion","volume":"51","author":"Feng","year":"2023","journal-title":"J Int Med Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002165","article-title":"COMBINATION THERAPY OF INTRAVITREAL RANIBIZUMAB AND SUBTHRESHOLD MICROPULSE PHOTOCOAGULATION FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION: 6-MONTH RESULT","volume":"39","author":"Terashima","year":"2019","journal-title":"Retina"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2018.2141","article-title":"Combination of grid laser photocoagulation and a single intravitreal ranibizumab as an efficient and cost-effective treatment option for macular edema secondary to branch retinal vein occlusion","volume":"22","author":"Cao","year":"2019","journal-title":"Rejuvenation Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.010","article-title":"One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema","volume":"119","author":"Do","year":"2012","journal-title":"Ophthalmology"},{"key":"B15","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jcjd.2013.08.140","article-title":"A canadian 12-month, Phillb study of ranibizumab combination or monotherapy in visual impairment due to diabetic(\u201cRESPOND\u201d)","volume":"37","author":"Berger","year":"2013","journal-title":"Can J Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.02.019","article-title":"A randomized trial to assess functional andstructural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study)","volume":"157","author":"Comyn","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study:ranibizumab monotherapy or combined with laser versus laser monotherapy fordiabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"B18","article-title":"Efficacy and safety of ranibizumab 0.5 mg as monotherapy or adjunctive to laser versus laser monotherapy in Asian patients with visual impairment due to diabetic macular edema: 12-month results of the REVEAL study","volume":"53","author":"Ohji","year":"2012","journal-title":"Invest Ophtalmol Visual Sci"},{"key":"B19","volume-title":"Meta-analysis of efficacy and safety of Leizumab and laser photocoagulation in the treatment of diabetic macular edema","author":"Liao","year":"2015"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00591","article-title":"Endothelial dysfunction in diabetic retinopathy","volume":"11","author":"Gui","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2016.08.054","article-title":"Evidence for pro-angiogenic functions of VEGF-ax","volume":"167","author":"Xin","year":"2016","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.04.018","article-title":"Occludin S490 phosphorylation regulates vascular endothelial growth factor-induced retinal neovascularization","volume":"186","author":"Liu","year":"2016","journal-title":"Am J Pathol"},{"key":"B24","article-title":"Research progress of anti-VEGF drugs in the treatment of macular edema","volume":"20","author":"Shan","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2013.03.004","article-title":"Ranibizumab injection for diabetic macular edema: meta-analysis of systemic safety and systematic review","volume":"48","author":"Abouammoh","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"B26","article-title":"Single intravitreal injection of leizumab combined with laser in the treatment of macular edema secondary to central retinal vein obstruction","volume":"19","author":"Zhiwei","year":"2019","journal-title":"Chin J Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.4284","article-title":"Five-year cost-effectiveness of intravitreous ranibizumab therapy vs panretinal photocoagulation for treating proliferative diabetic retinopathy: A secondary analysis of a randomized clinical trial","volume":"137","author":"Hutton","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"B28","article-title":"Laser combined with intravitreal injection of Compaplomb for diabetic macular edema","volume":"45","author":"Hui","year":"2018","journal-title":"Chin J Pract Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/aos.17535","article-title":"Consensus-based recommendations for indications and procedures in retinal laser treatment of Telangiectatic capillaries (TelCaps) in vascular macular oedema: A Delphi study","author":"Delyfer","year":"2025","journal-title":"Acta Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S236423","article-title":"Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options","volume":"15","author":"Veritti","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042701","article-title":"A safety review and meta-analyses ofbevacizumab and ranibizumab: off-label versus goldstandard","volume":"7","author":"Schmucker","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:37:52Z","timestamp":1789562272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1608456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":31,"alternative-id":["10.3389\/fendo.2025.1608456"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1608456","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1608456"}}